AKYA Akoya Biosciences Inc

USD 2.19 -0.02 -0.904977
Icon

Akoya Biosciences Inc (AKYA) Stock Analysis and Price Targets

COMMON STOCK | Medical Instruments & Supplies | NSD
stockTargetAdvisor

Strong Buy

Average Analyst
Rating
stockTargetAdvisor

Strong Buy

Top Analyst
Rating
stockTargetAdvisor

Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

Strong Buy

Average User
Rating

USD 2.19

-0.02 (-0.90)%

USD 0.10B

0.33M

USD 7.25(+231.05%)

USD 15.00 (+584.93%)

Icon

AKYA

Akoya Biosciences Inc (USD)
COMMON STOCK | NSD
USD 2.19
0.00 0
Take a Tour
stockTargetAdvisor

Strong Buy

Average Analyst
Rating
stockTargetAdvisor

Strong Buy

Top Analyst
Rating
stockTargetAdvisor

Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

Strong Buy

Average User
Rating

USD 0.10B

USD 15.00 (+584.93%)

USD 2.19

Akoya Biosciences Inc (AKYA) Stock Forecast

Show ratings and price targets of :
USD 7.25
(+231.05%)

Based on the Akoya Biosciences Inc stock forecast from 5 analysts, the average analyst target price for Akoya Biosciences Inc is USD 7.25 over the next 12 months. Akoya Biosciences Inc’s average analyst rating is Strong Buy. Stock Target Advisor’s own stock analysis of Akoya Biosciences Inc is Bearish, which is based on 1 positive signals and 7 negative signals. At the last closing, Akoya Biosciences Inc’s stock price was USD 2.19. Akoya Biosciences Inc’s stock price has changed by +8.96% over the past week, -48.65% over the past month and -59.22% over the last year.

No recent analyst target price found for Akoya Biosciences Inc
No recent average analyst rating found for Akoya Biosciences Inc

Company Overview Akoya Biosciences Inc

Akoya Biosciences, Inc., a life sciences technology company, provides spatial biology solutions focused on transforming discovery and clinical research in North America, the Asia Pacific, Europe, the Middle East, and Africa. The company offers PhenoCycler instrument, a compact be...Read More

https://www.akoyabio.com

100 Campus Drive, Marlborough, MA, United States, 01752

330

December

USD

USA

Adjusted Closing Price for Akoya Biosciences Inc (AKYA)

Loading...

Unadjusted Closing Price for Akoya Biosciences Inc (AKYA)

Loading...

Share Trading Volume for Akoya Biosciences Inc Shares

Loading...

Compare Performance of Akoya Biosciences Inc Shares

Symbol Capital Gain Dividend Return Total Return
Loading...
Loading...

Technical Indicators for AKYA

Assets

Top Holdings

Top Sectors

Top Regions

Stocks Similar To Akoya Biosciences Inc (Sector: Medical Instruments & Supplies )

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
ISRG
Intuitive Surgical Inc +0.40 (+0.10%) USD148.13B 75.25 59.92

ETFs Containing AKYA

Symbol Name AKYA's Weight Expense Ratio Price(Change) Market Cap
no data

Frequently Asked Questions About Akoya Biosciences Inc (AKYA) Stock

Based on ratings from 5 analysts Akoya Biosciences Inc's stock is Strong Buy. Stock Target Advisor's fundamental analysis is Bearish. The stock has 6 buy, sell and hold ratings.

Unfortunately we do not have enough data on AKYA's stock to indicate if its a good dividend stock.

Based on targets from 5 analysts, the average taret price for AKYA is USD 7.25 over the next 12 months. The maximum analyst target price is USD 10 while the minimum anlayst target price is USD 4.

Unfortunately we do not have enough data on AKYA's stock to indicate if its overvalued.

The last closing price of AKYA's stock was USD 2.19.

The most recent market capitalization for AKYA is USD 0.10B.

Based on targets from 5 analysts, the average taret price for AKYA is projected at USD 7.25 over the next 12 months. This means that AKYA's stock price may go up by +231.05% over the next 12 months.

We can't find any ETFs which contains Akoya Biosciences Inc's stock.

As per our most recent records Akoya Biosciences Inc has 330 Employees.

Akoya Biosciences Inc's registered address is 100 Campus Drive, Marlborough, MA, United States, 01752. You can get more information about it from Akoya Biosciences Inc's website at https://www.akoyabio.com.
Heading 1 Heading 2 Heading 3 Heading 4 Heading 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...